Your Omega-3 Supplement May Not Help Your Brain
Fish oil has been marketed as a brain supplement for decades.
New research suggests that promise may not hold up — and the reasons are more specific, and more surprising, than most people assume.
A Brain Injury Study Found the Opposite of What Researchers Expected
A team at the Medical University of South Carolina, led by neuroscientist Onder Albayram, set out to study how fish oil affects the brain after repeated mild traumatic injuries.
What they found ran counter to the existing assumption that omega-3s universally protect and heal the brain.
Published in the journal *Cell Reports*, the study showed that eicosapentaenoic acid (EPA) — one of the two primary omega-3s in fish oil — appeared to disrupt the brain's ability to heal after injury, rather than support it.
Mice given EPA after repeated mild brain injuries performed worse on spatial memory and learning tasks than mice that did not receive it, according to ScienceAlert.
The mechanism, the researchers found, involves EPA reprogramming the metabolic activity of blood vessels in the brain, interfering with vascular repair processes that would otherwise help the brain recover.
📰 Related: Antibacterial Soap May Be Breeding Superbugs, Study Warns
The Researchers Are Not Saying to Abandon Fish Oil
Albayram was careful to frame the findings narrowly.
"Biology is context-dependent," he told *Medical News Today*, emphasizing that this is not a call for the general public to stop taking fish oil supplements.
The effects were observed in a rodent model, not directly in humans, and the dose of EPA required to produce an equivalent effect in people remains unclear.
The findings appear most relevant to a specific group: athletes in contact sports, military service members, and others at elevated risk of repeated mild traumatic brain injuries — the population the study was designed to examine.
Separately, a 2025 systematic review found that low-dose omega-3 supplements are associated with cognitive benefits, but that high doses above 1,500 mg a day may reverse that advantage in some patients, reinforcing the idea that more is not automatically better when it comes to brain-targeted supplementation.
📰 Related: GLP-1 Drugs May Boost Male Fertility, New Study Finds
The Other Reason Your Fish Oil May Not Be Working
There is a second, entirely separate problem that has nothing to do with brain injury or dosage — and it may affect far more people.
A significant share of fish oil supplements on the market are already degraded before they reach the consumer.
A study published in the *Journal of Dietary Supplements* tested 72 of the most popular fish oil brands and found that 45% tested positive for rancidity — meaning the oil had already oxidized.
Oxidation directly reduces the nutritional benefit the supplement is supposed to deliver, according to researchers at George Washington University, who conducted the testing.
Flavoring is often added specifically to mask the rancid smell and taste, the same study found — meaning a pleasant-tasting fish oil capsule is not necessarily evidence of freshness.
Consumer Reports' own testing of 20 popular fish oil brands, conducted between January and May 2025, found that 16 of 20 brands met quality and safety standards — leaving four that did not, the organization confirmed.
📰 Related: Millions Take Calcium and Vitamin D for Bone Health. A Major Review Finds Limited Benefit
How to Tell If the Supplement in Your Cabinet Is Still Working
Quality testing organizations measure oxidation using a combined metric called TOTOX — peroxide value plus twice the anisidine value.
A TOTOX score under 10 is considered fresh; many tested products exceed accepted safety limits, with some industry estimates suggesting up to 60% of products on the market fall outside recommended oxidation thresholds.
Practical signs of a degraded supplement include a strong fishy odor or aftertaste, repeated burping after consumption, and discolored capsules — all indicators that oxidation has likely already occurred regardless of what the label claims.
Re-esterified triglyceride (rTG) forms of omega-3 are more chemically stable than the ethyl ester forms used in many older supplement formulations, and individually sealed, oxygen-barrier packaging slows the oxidation process considerably compared to standard bottling.
Between a brain that may not respond to omega-3s the way marketing suggests, and a supplement industry where nearly half of tested products are already degraded, the case for "just taking fish oil" is considerably less straightforward than it appeared a decade ago.
The omega-3 market itself is not slowing down — global demand for unsaturated fatty acid products was valued at $13.88 billion in 2025 and is projected to reach $24.56 billion by 2034, even as the underlying science grows more complicated.
Key Takeaways
- A Medical University of South Carolina study published in *Cell Reports* found that EPA, a primary omega-3 in fish oil, may disrupt brain healing after repeated mild traumatic injuries in a mouse model.
- The effect appears most relevant to athletes in contact sports, military personnel, and others at elevated risk of repeated head injuries — not the general public.
- A 2025 systematic review found that omega-3 doses above 1,500 mg a day may reverse cognitive benefits seen at lower doses.
- A separate study of 72 popular fish oil brands found that 45% tested positive for rancidity, reducing the nutritional benefit delivered.
- Flavoring is often added specifically to mask rancid taste and smell, meaning taste alone is not a reliable freshness indicator.
- Consumer Reports' 2025 testing of 20 popular brands found 4 did not meet quality and safety standards.
Sources
Also Read
Health & Science Correspondent
Dr. Chris Farley brings a medical background to his reporting on healthcare policy, scientific research, and global health developments. He makes complex medical news easy to understand.
